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Sirt3 is a mitochondrial sirtuin, predominantly expressed in highly metabolic tissues. Germline ablation of
Sirt3 has major metabolic consequences, including increased susceptibility to metabolic damage and
oxidative stress after high fat feeding. In order to determine the contribution of liver and skeletal muscle to
these phenotypes, we generated muscle-specific Sirt3 (Sirt3
skm2/2) and liver-specific Sirt3 (Sirt3
hep2/2)
knock-out mice. Despite a marked global hyperacetylation of mitochondrial proteins, Sirt3
skm2/2 and
Sirt3
hep2/2 mice did not manifest any overt metabolic phenotype under either chow or high fat diet
conditions. Similarly, there was no evidence for increased oxidative stress in muscle or liver when Sirt3 was
ablated in a tissue-specific manner. These observations suggest that the mitochondrial hyperacetylation
induced by Sirt3-deletion in a tissue specific manner is not necessarily linked to mitochondrial dysfunction
and does not recapitulate the metabolic abnormalities observed in the germline Sirt3 knock-out mice.
S
irt3isoneofthe7membersofthesirtuinfamilyofNAD
1-dependentdeacetylases.TogetherwithSirt4and
Sirt5, Sirt3 localizes predominantly in the mitochondria
1. Importantly, Sirt3 is a primary regulator of
mitochondrial protein acetylation. The absence of Sirt3 enhances global acetylation of mitochondrial
proteins,whilenosignificantchangesinproteinacetylationwereobservedinSirt4
2/2andSirt5
2/2mitochondria
2.
Sirt3 expression is highly enriched in metabolic tissues like liver, brown adipose tissue (BAT), heart, skeletal
muscle and kidney
3. Sirt3 expression increases in muscle after exercise training, fasting and caloric restriction
(CR), while it decreases upon long-term high fat feeding
4,5. In liver and BAT Sirt3 expression also increases after
CR and fasting, as well as upon cold exposure in BAT
3,6.
Germline Sirt3
2/2 mice display increased levels of cellular reactive oxygen species (ROS)
7–12 and impaired
cellular respiration after prolonged fasting
6 in different tissues, including the muscle, liver, brain or the inner ear.
Incontrast,Sirt3overexpressioninvitroenhancesmitochondrialrespiration
13andreducesROSproduction
3.Not
surprisingly, whole body Sirt3 knock-out mice are sensitized to high fat diet (HFD)-induced obesity, insulin
resistance,hyperlipidemia andsteatohepatitis
14.TheetiologyofsuchdefectsmightbefoundintheabilityofSirt3
to enhance fat oxidation and improve anti-oxidant defences
6,9,10,14–16. However, while recent reports show that
Sirt3 suppresses oxidative stress under CR
9,10,12, it still remains to be elucidated whether Sirt3 might influence
HFD-induced oxidative stress.
All studies to date used germline Sirt3 deficient mice to study the role of Sirt3 on metabolism, making it
impossible to distinguish the contribution of individual tissues to the phenotypic changes. Liver and muscle are
two of the most important tissues determining whole body metabolism: skeletal muscle is the largest organ in
mammals, contributing to 640% of the body mass, and it plays a major role in whole body metabolism, as it is
vital for insulin-mediated glucose disposal and lipid catabolism. In turn, the liver is central to regulate glucose,
lipid and cholesterol homeostasis. Altered function of these tissues is, thus, likely to contribute to the systemic
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mice. Here, we report the generation of the first set of tissue-specific
Sirt3 knockout mouse models in muscle and liver, and describe how
Sirt3 deletion in these tissues, despite leading to mitochondrial pro-
teinhyperacetylation,hasminorphenotypicconsequences.Thissug-
geststhatthemetabolicabnormalitiesobservedinthegermlineSirt3-
KO mice may not stem from the liver or muscle deficiencies.
Results
Generation of the Sirt3
skm2/2 and Sirt3
hep2/2 mice. To investigate
the role of Sirt3 in muscle and liver, as well as its impact on whole
body metabolism, we generated a mouse line in which exons 2 and 3
were flanked with LoxP sites, priming it for subsequent deletion
using the Cre-LoxP system (Fig. 1A). Sirt3
L2/L2 mice, bearing floxed
Sirt3 L2 alleles, were bred with mice expressing the Cre recombinase
under the control of the human a-skeletal actin promoter
17, yielding
HSA-Cre
Tg/0/Sirt3
L2/L2 mutants (Sirt3
skm2/2), in which Sirt3 is
selectively ablated in the skeletal muscles. A distinct mouse line, in
which Cre expression was under the control of the albumin
promoter
18, was used to generate Alb-Cre
Tg/0/Sirt3
L2/L2 mice
(Sirt3
hep2/2), in which Sirt3 is selectively ablated in the liver.
Sirt3
skm2/2 and Sirt3
hep2/2 mice were born at a normal Mendelian
ratio and had a normal appearance. Only residual Sirt3 mRNA levels
were detected in skeletalmuscle(gastrocnemius, soleus and EDL)of 8-
week-old Sirt3
skm2/2 mice (Fig. 1B), demonstrating that Sirt3 was
efficiently ablated in Sirt3
skm2/2 muscles. In addition to the skeletal
muscle, a 35% reduction in Sirt3 mRNA levels was observed in the
heart of Sirt3
skm2/2 mice, whereas no significant reduction was seen in
other tissues (Fig. 1B). Sirt3 mRNA levels were also blunted in livers
from Sirt3
hep2/2 mice of 8 weeks of age, but normal in other tissues
(Fig. 1C). In line with the above results, the Sirt3 protein was unde-
tectable in the skeletal muscle of Sirt3
skm2/2 mice, but remained un-
affected in the liver (Fig. 1D); conversely the Sirt3 protein was only
absent in the liver in the Sirt3
hep2/2 mice (Fig. 1E), confirming that the
Sirt3 deletion is efficient and restricted to the targeted tissue.
The absence of Sirt3 had no impact on the expression of a vast set
of metabolic genes in either muscle (Fig. 1F) or liver (Fig. 1G). Of
note, we did not detect any compensatory increase in the expression
of the other mitochondrial sirtuins (Sirt4 and Sirt5) in the two Sirt3-
deficienttissues.WealsodeterminedPgc1aandScd1expression,two
genes whose levels were reported to be altered in germline Sirt3-KO
tissues
5,14; however, we could not detect any significant change in
their expression in our mutant mice. These results suggest that
Figure 1 | Generation,validation andexpressionofmetabolic genesfortheSirt3
hep2/2andSirt3
skm2/2mice. (A)Targetingstrategy usedtogenerate the
tissue-specific Sirt3-deficient mice. Maps of the Sirt3 genomic locus showing the conditional allele (upper panel) and the KO allele (lower panel). The
whitearrowheadsindicatetheLoxPsitesandtheblackverticalbarsrepresenttherespectiveexons.(B–C)Sirt3mRNAexpressionlevelsindifferenttissues
of Sirt3
skm1/1 and Sirt3
skm2/2 mice (B) and of Sirt3
hep1/1 and Sirt3
hep2/2 mice (C); n54 per group. (D–E) Sirt3 protein expression as assessed by western
blotting in muscle (D) and liver (E) of the Sirt3-deficient mouse models. Porin is used as a loading control. (F–G) Gene expression in gastrocnemius
muscle of Sirt3
skm1/1 and Sirt3
skm2/2mice (F) and in liver of Sirt3
hep1/1 and Sirt3
hep2/2 mice (G) after 18 weeks of HFD. mRNA levels were normalized to
36B4. Data represent the mean 6 SEM for at least four animals per group.
www.nature.com/scientificreports
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on the expression of genes involved in metabolic control. We only
performed this gene expression analysis in mice subjected to HFD,
since young, unchallenged mice show no phenotype whatsoever,
both in our hands and in previous reports
2.
Normal metabolic phenotype in Sirt3
hep2/2 mice fed chow or high
fat diet. We next subjected Sirt3
hep1/1 and Sirt3
hep2/2 mice to a
standardized phenotyping protocol before and after high fat diet
(HFD) feeding (Fig. 2A). Body weight and body composition were
similar in both genotypes before and after HFD (Fig. 2B and 2C).
The weight gain curves of the Sirt3
hep2/2 mice were indistinguishable
from those of the Sirt3
hep1/1 mice (data not shown). During indirect
calorimetry using the comprehensive lab animal monitoring system
(CLAMS), no difference was observed in food intake (Fig. 2D), mean
VO2 (Fig. 2E), mean respiratory exchange ratio (RER) (Fig. 2F) or
spontaneous locomotor activity (Fi g .2 G ) ,b e f o r ea n da f t e rH F D .A t
sacrifice, the weight of the liver, epididymal white fat or interscapular
brownfat depotswere notdifferentbetween the genotypes(Fig. 2H). To
specifically test the contribution of Sirt3 deletion in the liver to glucose
homeostasis we performed an intraperitoneal glucose tolerance test
(ipGTT) and an insulin tolerance test (ipITT) both before (data not
shown) and after HFD. Again no significant differences between
Sirt3
hep1/1 and Sirt3
hep2/2 animals were detected in these experiments
(Fig. 2I, 2J and data not shown). All these data contrast with the results
obtained in germline Sirt3-deficient mice, where Sirt3-deficiency was
shown to sensitize the liver to HFD-induced damage
14.
GermlineSirt3-KOmicehavealsobeenreportedtodisplayaltered
aminoacid profiles in blood and liver
15. We therefore also analyzed
the blood aminoacid profiles, but could not detect differences
between the Sirt3
hep2/2 and Sirt3
hep1/1 samples, both in the fed state
(data not shown) and after a 24 h fast (Fig. 2K).
Sirt3 has also been suggested to act as a key modulator of ketone
body production, a glucose-sparing energy substrate in the fasting
state mostly synthesized by hepatocytes
19. However, blood levels of
b-hydroxybutyrate, a surrogate marker of the activity of this path-
way, were similar in Sirt3
hep1/1 and Sirt3
hep2/2 mice both before and
after a 24 h fast at 8-weeks of age (Fig. 2L). This contrasts with the
germline Sirt3 knock-out mice, which displayed a maximal decrease
in b-hydroxybutyrate after a 24 h fast
19.
Finally, since germline Sirt3-KO mice display abnormal fatty
acid metabolism and aberrant blood acylcarnitine profiles
14,15,w e
analyzed the blood acylcarnitines in Sirt3
hep1/1 and Sirt3
hep2/2
animals in both fed (data not shown) and fasted (24 h fast) states
Figure 2 | Metabolic phenotyping of Sirt3
hep2/2 mice. (A) Experimental schedule of the clinical phenotyping protocol. MCB: non-invasive monitoring
ofbodyfatandleanmassbyEchoMRI,energyexpenditurebyindirectcalorimetry(CLAMSsystem),andbloodsamplingformetaboliteanalysis;I:intra-
peritoneal glucose tolerance test (ipGTT); T: intra-peritoneal insulin tolerance test (ipITT); {: sacrifice and collection of blood and organs for further
analysis. (B) Body weight and (C) body composition of Sirt3
hep1/1 and Sirt3
hep2/2mice before and after 8 weeks of HFD. (D–G) Daily food intake (D),
mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) asmeasured over a 24 h period
beforeandafterHFD.(H)RelativeweightoftissuesnormalizedbybodyweightinSirt3
hep1/1andSirt3
hep2/2mice.(I–J)Intra-peritonealglucosetolerance
test (ipGTT; I), and intra-peritoneal insulin tolerance test (ipITT; J) in mice fed a HFD for 15-17 weeks. The bar graphs represent the average area under
thecurve(AUC).(K)Levelsoftheindicatedaminoacidsweredeterminedinplasmafrom8weeksoldmalemice.(L)b-hydroxy-butyratewasanalysedin
plasma from 8 weeks old male mice before and after a 24h fasting period. (M) Acylcarnitine levels in plasma from 8 weeks old male mice. Results are
represented as mean values (n58210 mice for each group) 6 standard error of the mean (SEM).
www.nature.com/scientificreports
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the acylcarnitine levels between the two genotypes.
All these findings combined suggest that the altered metabolic
response of germline Sirt3-KO mice subjected to HFD
14 or to fast-
ing
15,19 are not due to the absence of Sirt3 in hepatocytes, but rather
stem from the indirect effect of Sirt3 ablation in some other tissue.
No metabolic phenotype in Sirt3
skm2/2 mice under chow or high
fat diet. We next determined whether the phenotype observed in
the germline Sirt3 knock-out mice could be due to another major
metabolic tissue, i.e. the skeletal muscle. We therefore subjected
Sirt3
skm2/2 and Sirt3
skm1/1 mice to a similar phenotyping protocol
than the one described for the liver-specific Sirt3-deficient mice
(Fig. 3A). No differences in body weight (Fig. 3B) and body
composition (Fig. 3C) were observed between Sirt3
skm2/2 and
Sirt3
skm1/1 mice, even under HFD conditions. Consistent with
the similarities in body weight, evaluation using CLAMS
indicated that food intake (Fig. 3D), mean VO2 (Fig. 3E), mean
RER (Fig. 3F) and spontaneous locomotor activity (Fig. 3G) were
similar between the two genotypes before and after HFD. In
addition, no significant differences were observed in the weight
of different tissues at sacrifice (Fig. 3H). Upon an intraperitoneal
glucose tolerance test (ipGTT) the glucose excursion (Fig. 3I; left
panel) and glucose-induced insulin secretion (Fig. 3I; right panel)
were comparable between the two genotypes. Also, the drop and
recovery of blood glucose levels upon an intraperitoneal insulin
tolerance test (ipITT) were, again, not distinct between the two
genotypes (Fig. 3J).
To further evaluate possible phenotypic differences between the
Sirt3
skm2/2 and Sirt3
skm1/1 mice, we exposed the mice to a cold chal-
lenge (4uC). Mice from both genotypes similarly maintained their
core body temperature for at least 6 hours after a 24 h fast (Fig. 3K),
orafter14weeksof HFD(Supl. Fig.1A), indicating thatmuscleSirt3
is not essential for cold-induced adaptive thermogenesis. Exercise
increases Sirt3 expression in muscle
4,5, suggesting a role for Sirt3 in
exercise physiology. Sirt3
skm2/2 and Sirt3
skm1/1 mice, however, ran a
similardistanceuntilexhaustionbothbeforeandafterHFD(Fig.3L).
Alsonodifferenceinendurancerunningwaspresentbeforeandafter
a 24 h fast (Supp. Fig. 1B). In addition, both the heart rate (Fig. 3M)
andsystolicbloodpressure(Fig.3N)weresimilarbetweenSirt3
skm2/2
and Sirt3
skm1/1 mice, indicating that the partial reduction in Sirt3
mRNA levels found in the Sirt3
skm2/2 hearts has no major impact on
cardiac function.
Altogether, these data indicate that Sirt3
skm2/2 mice are metaboli-
callyindistinguishablefromcontrolmiceunderbothchowandHFD.
Thus, the absence of Sirt3 in the skeletal muscle by itself cannot
Figure 3 | Metabolic phenotyping of Sirt3
skm2/2 mice. (A) Experimental schedule of the clinical phenotyping protocol. For abbreviations see legend of
Fig. 2A; E: endurance exercise on a treadmill; N: non-invasive blood pressure measurement (NIBP); C: cold test. (B) Body weight and (C) body
composition of Sirt3
skm1/1 and Sirt3
skm2/2mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean
respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative
weight oftissues normalized by body weight in Sirt3
skm1/1andSirt3
skm2/2mice. (I)Intra-peritoneal glucose tolerance test(ipGTT, leftpanel) and plasma
insulinduringipGTT(rightpanel)inmicefedaHFDfor16weeks.(J)Intra-peritonealinsulintolerancetest(ipITT)inSirt3
skm1/1andSirt3
skm2/2micefed
aHFD for17 weeks. (I and J) The bar graph (inner panels) represents the average area under the curve (AUC). (K) Sirt3
skm1/1and Sirt3
skm2/2mice fasted
for24hwereexposedto4uCfor6 handrectaltemperaturewasmonitored.(L)EnduranceexercisetestonSirt3
skm1/1andSirt3
skm2/2micebeforeandafter
12 weeks of HFD. (M) Heart rate and (N) systolic blood pressure were measured in Sirt3
skm1/1 and Sirt3
skm2/2mice after 10 weeks on HFD. Results are
presented as mean values (n58210 mice for each group) 6 SEM.
www.nature.com/scientificreports
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Sirt3-KO animals.
Mitochondrial protein hyperacetylation but normal oxidative
stress in Sirt3-deficient tissues. The fact that Sirt3 is a mito-
chondrial protein prompted us to investigate the integrity of the
mitochondria in both tissue-specific Sirt3
2/2 mouse models after
HFD treatment, a stress after which we expect the effects of Sirt3
deficiency to be accentuated. The protein levels of subunits from the
mitochondrial respiratory complexes I, II, IV and V were indis-
tinguishable in Sirt3
skm2/2 and Sirt3
skm1/1 muscle, and in Sirt3
hep2/2
and Sirt3
hep1/1 liver (Fig. 4A). In line with the observations in
germline Sirt3
2/2 mice
2, there was a marked increase in global
mitochondrial protein acetylation in the tissues where the Sirt3
gene had been deleted (Fig. 4B and 4C). We next evaluated the
acetylation levels of specific Sirt3 targets. Sirt3 interacts with
and deacetylates Ndufa9, a subunit of complex I
13. Consistently,
we observed increased acetylation of some members of the
Ndufa9-containing complex I in livers from the Sirt3
hep2/2 mice or
quadriceps muscle from the Sirt3
skm2/2 mice, as compared with their
respective wild type controls (Fig. 4D, top panels). However, this
increased acetylation did not lead to any change in maximal com-
plex I or complex IV activities (Fig. 4E). As an internal control, we
measured the activity of citrate synthase, a mitochondrial enzyme
from the Krebs cycle not belonging to the electron transport chain,
whose activity was also unchanged in the absence of Sirt3 in both
mouse models (Fig. 4E). To further examine mitochondrial function
in the absence of Sirt3 we measured oxygen consumption in Sirt3
L2/L2
primary hepatocytes-with the Sirt3 gene flanked with LoxP sites- in
which we acutely deleted the Sirt3 gene by an adenoviral infection
with Cre. Oxygen consumption rate (OCR) was not affected by the
absence of Sirt3 (Fig. 4F and Suppl. Fig. 2A).
Sirt3 deficiency has also been correlated with low levels of cellular
ATP
13. We therefore measured ATP levels in Sirt3
skm1/1 and Sirt3
skm2/2
gastrocnemius muscle and in Sirt3
hep1/1 and Sirt3
hep2/2 liver, but could
not detect differences between tissues from the different genotypes
Figure 4 | Hyperacetylation of mitochondrial proteins but normal ROS markers in Sirt3
hep2/2 and Sirt3
skm2/2 mice subjected to HFD. (A) Protein
expression levels of complex I, II, IV and V in isolated mitochondria of Sirt3
skm1/1 and Sirt3
skm2/2muscle (left panels) and Sirt3
hep1/1and Sirt3
hep2/2livers (right
panels). (B, C) Acetylation status of mitochondrial proteins extracted from muscle and liver of Sirt3
skm1/1and Sirt3
skm2/2mice (B) and Sirt3
hep1/1and Sirt3
hep2/2
mice (C). Mitochondrial protein lysates were subjected to western blotting using an anti-acetylated lysine antibody (Ac-K) and porin as a loading control.
(D) Acetylation level of complex I members (top two rows of panels) and Sod2 (bottom two rows of panels) in Sirt3
skm1/1and Sirt3
skm2/2muscle (left panels) or
Sirt3
hep1/1 and Sirt3
hep2/2 livers (right panels). Endogenous Ndufa9 or Sod2 were immunopurified from muscle lysates and immunoblotted using Ndufa9/Sod2
and Ac-K antibodies. (E) Complex I (CI), complex IV (CIV) and Citrate synthase (CS) activities in Sirt3
skm1/1 and Sirt3
skm2/2muscle (left panel) or Sirt3
hep1/1
and Sirt3
hep2/2 (right panel). (F) Oxygen consumption rate (OCR) from primary hepatocytes obtained from Sirt3
L2/L2 mice infected with the indicated viruses.
(G) ATP levels were measured from the indicated tissue lysates. (H–K) Activities of mitochondrial Sod2 (H) and catalase (I) and levels of 4-hydroxy-2-nonenal
(HNE; J) and GSH/GSSG ratio (K) in muscle and liver lysates of Sirt3
skm1/1 and Sirt3
skm2/2mice (left panels) or Sirt3
hep1/1 and Sirt3
hep2/2mice (right panels).
Measurements in panels E–K were determined using samples from at least four mice per genotype. All the samples used for these studies come from mice
subjected to the HFD treatment, sacrificed in fed state. Data are represented as mean 6 SEM.
www.nature.com/scientificreports
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ylation status of the AMP/ATP sensing AMP-activated protein kinase
(AMPK), suggesting that Sirt3 deletion in a tissue-specific fashion does
not affect intracellular energy charge (Suppl. Fig. 2B).
Sirt3 has been shown to reduce oxidative stress, mostly through
deacetylating and activating the mitochondrial ROS scavenger
Sod2
9,10,12,16. We therefore also determined Sod2 acetylation status
in the absence of Sirt3; as reported, Sirt3-deficient tissues presented
increased levels of acetylated Sod2 (Fig. 4D, lower panels). In con-
trast, Sirt3 gene ablation did not affect the activity of Sod2 (Fig. 4H),
nor that of catalase, another key ROS scavenger (Fig. 4I). We next
measured a few markers of oxidative stress, such as the level of 4-
hydroxy-2-nonenal (HNE; a marker for lipid peroxidation) and glu-
tathione, in liver and muscle from our mutant mouse models after
HFD treatment. No difference in these parameters was observed
between Sirt3-deficient tissues and their respective controls
(Fig. 4J-K). These results show that tissue-specific ablation of Sirt3
results in increased acetylation of ROS scavengers, but that this
alteration is not sufficient to affect their activity, which may help
to explain the lack of a metabolic phenotype in these two tissue-
specific Sirt3 deficient mouse models.
Discussion
We report here the generation and phenotypic characterization of
the first set of tissue-specific Sirt3 knockout mice (muscle-specific
Sirt3
skm2/2 and liver-specific Sirt3
hep2/2 mice). Consistent with the
role of Sirt3 as the major mitochondrial deacetylase
2, mitochondrial
proteins were robustly hyperacetylated in Sirt3-deficient tissues. In
line with this observation, specific Sirt3 targets, such as mitochon-
drial complex I and the mitochondrial ROS scavenger, Sod2, were
also markedly hyperacetylated in Sirt3-deficient tissues (Fig. 4D), as
previously described in livers from the germline Sirt3
2/2 mice
9,12,13.
However, the activities of these enzymes (Fig. 4H–I) were not chan-
gedinSirt3-deficienttissues,whichindicatesthathyperacetylationof
these proteins does not necessarily result in a change in their max-
imal activity. Indeed, while many residues might be acetylated in a
single protein, only the acetylation of a few key residues crucially
determinestheenzymaticactivity/functionoftheprotein,asdemon-
strated with LCAD
6. This phenomenon might explain the lack of a
metabolic phenotype in the tissue-specific Sirt3-deficient mice.
Several in vivo and in vitro studies demonstrated a role for Sirt3 in
the suppression of oxidative stress
3,8–12,16. However, different groups
have reported normal ROS levels in basal state in liver, brain or
cochlea
9,10. In line with these last reports, we observed normal levels
of surrogate markers for ROS in Sirt3-deficient tissues, as well as
similar levels of activity of the mitochondrial ROS scavengers Sod2
and catalase (Fig. 4 H–I). Again, these results might explain the lack
of a clear metabolic phenotype in the conditions we tested.
Despite the higher mitochondrial protein hyperacetylation, the
tissue-specific Sirt3
2/2 mice described here were metabolically sim-
ilar to control littermates in all the conditions that we tested (chow
and HFD diet, 24 h fasting, exercise or cold). Our results therefore
imply that the previously described phenotypes of germline Sirt3
2/2
animals under a short fasting or HFD
6,9–11,13-15,19 are not due to the
absence of Sirt3 specifically in liver or muscle. Rather, our data indi-
cate that either Sirt3 deficiency in another tissue or the coordinated
defect of Sirt3 in multiple tissues accounts for these effects in the
germline Sirt3 knock-out mice. In this regard, our results do also not
rule out the possibility that latent defects in muscle or liver function
in our models can be fully compensated by another tissue or sirtuin
function. In this sense, further tissue-specific Sirt3 deficient mouse
models exploring the brain, white or brown adipose, or macrophage
function of Sirt3 will be key to fully evaluate the etiology of the
metabolic alterations in the germline Sirt3 knock-out mice. In this
context it is interesting to note that no change in Sirt3 mRNA or
protein expression in non-targeted tissues (Fig. 1B, 1C, 1D and 1E),
nor any change in the mRNA levels of the other mitochondrial
sirtuins (Sirt4 and Sirt5) in the Sirt3-targeted tissues (Fig. 1F and
1G) was present, which suggest that there is no compensation by
other mitochondrial sirtuins. These observations, however, do not
rule out a change in the activity, rather than in mRNA or protein
levels, of these sirtuins as the possible mechanism of compensation.
Of note is also that Sirt3
skm2/2 mice, when subjected to a 24 h fast
and, subsequently, to a cold test, do not suffer hypothermia, as prev-
iously reported for the whole-body Sirt3-KO mice
6. Since the two
maintissuesresponsiblefortemperaturehomeostasisaremuscleand
brown fat, and Sirt3 is highly expressed in this last tissue, it is tempt-
ing to speculate that Sirt3 in brown fat, but not in skeletal muscle,
plays an important role in temperature homeostasis, most probably
via regulation of mitochondrial uncoupling. Brown fat is also an
important tissue in fat and glucose clearance, and increased brown
fat amounts or activity can significantly improve global metabol-
ism
20,21. Thus, one possibility is that the brown fat tissue in
Sirt3
hep2/2 and Sirt3
skm2/2 mice could compensate for the tissue-spe-
cific ablation of Sirt3 in liver or muscle.
Finally, when comparing studies from different laboratories, it is
important to bear in mind that the genetic background and/or the
exact composition of the diets are key determinants of phenotypic
outcome,whichistheresultofgene-environmentinteractions
22,23.In
this regard, our mice were on an obesity-prone background (C57BL/
6)
23–25 and fed with a standard HFD, with 60% calories coming from
fat, both conditions being different from those used in other
reports
14. Furthermore, differences in the developmental onset of
the Sirt3 gene deletions need to be considered, as germline Sirt3-
KO mouse model lacks Sirt3 from the beginning of embryonic
development, while the tissue-specific promoters used in our work
are activated only from a certain developmental stage.
In summary, our work confirms the critical impact of Sirt3 on
global mitochondrial acetylation. It is unclear why these alterations
donothaveamajorphysiologicalimpactwhenoccurringinatissue-
specific manner in muscle or liver, as in our study. Further investi-
gations to understand this conundrum are therefore warranted.
Methods
Generation and clinical phenotyping of the Sirt3
hep2/2 and Sirt3
skm2/2 mice. Sirt3
floxed (Sirt3
L2/L2) mice were generated using standard gene targeting procedures
26.
These animals were crossed with liver-specific Cre-expressing mice (Alb-Cre)
18 to
obtain the Sirt3
hep2/2 mouse line; or with the skeletal muscle-specific Cre-expressing
line (HSA-Cre)
17 to obtain the Sirt3
skm2/2 line. These two mouse lines were
backcrossed onto a pure C57BL/6J background. All animal work in the manuscript
has been performed according to the validated standard operating procedures
(SOPs)
23, as defined and validated by the Eumorphia program (see: http://
empress.har.mrc.ac.uk/). Briefly, we subjected our mice to non-invasive monitoring
of body fat and lean mass by EchoMRI; energy expenditure analysis by indirect
calorimetry (CLAMS system); intraperitonealglucose tolerance test (ipGTT); insulin
tolerance test (ipITT); blood sampling before and after a 24 fast; endurance exercise
on a treadmill; non-invasive blood pressure measurement; and cold test. A summary
of these methods is given in the supplementary materials and methods section.
Animal experiments were approved by the ethic veterinary committee of the canton
of Vaud - Switzerland (Permit IDs 2307 and 2307-1).
Quantitative RT-PCR. qRT-PCR was performed as already described
27,28. Briefly,
RNA was extracted from tissues using TRIzol reagent (Invitrogen). Complementary
DNA was generated using QuantiTect Rev (Qiagen). The real-time PCR
measurement of individual cDNAs was performed using SYBR green dye to measure
duplex DNA formation with the LightCycler System (Roche Diagnostics). Primer
sequences are listed in the supplementary materials and methods section.
ComplexI,complexIVandcitratesynthaseactivityassays.ComplexI,complexIV
and citrate synthase enzymatic activities were measured in homogenates of
gastrocnemius muscle of Sirt3
skm1/1 and Sirt3
skm2/2 or of livers of Sirt3
hep1/1 and
Sirt3
hep2/2 mice using the respective enzyme activity assay kits (Mitosciences), as
reported elsewhere
29.
Mitochondrial isolation, immunoprecipitation and western blot analysis.
Mitochondria were isolated from tissues following a previously described protocol
30.
Isolated mitochondria were lysed in RIPA lysis buffer containing protease inhibitors
and supplemented with 5 mM NAM and 1 mM sodium butyrate.
Immunoprecipitations were performed as described previously
28. Protein extracts
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 425 | DOI: 10.1038/srep00425 6were separated by SDS-PAGE. a-Sirt3 (home-made rabbit polyclonal against the
peptides CDLMQRERGKLDGQDR and STPSGIPDFRSPGSGL), a-Total OxPhos
(MitoSciences, MS604), a-Ndufa9 (Abcam, ab14713), a-AcK (Cell Signaling, 9441),
a-Sod2 (Santa Cruz, sc-133254 for IP, sc-3008 for WB), and a-porin (Calbiochem,
529536) antibodies were used to detect the respective proteins.
Analysis of blood metabolites. For b-hydroxybutyrate (BHBA) analysis, plasma
samples were precipitated with 1 M perchloric acid on ice. After centrifugation the
supernatant was neutralized using 2M KOH, 0.5 M 2-(N-
morpholino)ethanesulfonic acid (MES). BHBA concentrations were measured using
LC-MS/MS in the neutralized supernatant after removal of KClO4. Amino acids and
acylcarnitines were analyzed in plasma according to established LC-MS/MS
methods
31,32.
Evaluation of oxidative stress. Sod2 and catalase enzyme activity; HNE; and the
GSH/GSSGratioweremeasuredinliverorgastrocnemiusmusclehomogenatesusing
aSod2 andcatalase enzyme activityassays (CaymanChemicals);the OxiSelect HNE-
His Adduct ELISA Kit (Cell Biolabs Inc.); or the Bioxytech GSH/GSSG-412 kit
(OxisResearch TM), respectively, following the manufacturer’s protocols.
ATP measurements. ATP was measured in samples from liver or skeletal muscle
using the ATP determination kit (Molecular Probes, Invitrogen), following previous
reports
33 and the manufacturer’s instructions. Briefly, tissues were weighed and lysed
in600mlof6%(v/v)perchloricacid,andcentrifugedat4000xgfor10minutesat4uC.
500mlofthesupernatant wereneutralized with200mlof2.5 MKOH,andprecipitate
wasremovedbycentrifugationat4000xgfor5minutesat4uC.10mlofa1:10dilution
of the samples in 0.1 M Tris-HCl – 2 mM EDTA buffer (TE) were placed in an
appropriate bioluminescence plate, and luciferase activity was measured after
addition of 100ml of the reaction solution, with a lag time of 1 second and an
integration time of 3 seconds using a Glomax luminometer (Promega).
Preparation and culture of primary mouse hepatocytes and determination of
oxygen consumption rates. Liver cells were prepared by the two-step collagenase
method
34 from post-absorptive male mice (25–30 g) after anaesthesia with ketamin/
xylazin (1 mg/100 g body weight). Cell viability (.80%) was checked by trypan blue
exclusion. Primary culture of hepatocytes was seeded at 1.5310
4 per well on rat-ail
collagentype1(BDpharmingen)eitheroncoatedXF-96cellcultureplates(Seahorse)
oron12-wellplatesinserum-freeDMEM(4.5 g/lglucose) medium.Fourhoursafter
seeding, the medium was replaced by a glucose and serum free DMEM medium,
supplemented with lactate 10 mM and pyruvate 1 mM and the cells were infected
witheitheranadenoviruscontainingaGFPconstruct(Adeno-GFP)oranadenovirus
containing a recombinase Cre (Adeno-Cre) construct at a multiplicity of infection
(MOI) of 15. Cellular oxygen consumption rate (OCR) was measured by Seahorse
XF96 forty-eight hours after infection of cells as previously reported
35.
Statistical analyses. Statistical analyses were performed with non-parametric
Student’s t-test. Data are expressed as mean 6 SEM and p values smaller than 0.05
were considered as statistically significant. Statistical significance is displayed as
* (p , 0.05) or ** (p , 0.01).
1. Schwer, B., North, B. J., Frye, R. A., Ott, M. & Verdin, E. The human silent
information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide
adenine dinucleotide-dependent deacetylase. J Cell Biol 158, 647–657 (2002).
2. Lombard, D. B. et al. Mammalian Sir2 homolog SIRT3 regulates global
mitochondrial lysine acetylation. Mol Cell Biol 27, 8807–8814 (2007).
3. Shi, T., Wang, F., Stieren, E. & Tong, Q. SIRT3, a mitochondrial sirtuin
deacetylase, regulates mitochondrial function and thermogenesis in brown
adipocytes. J Biol Chem 280, 13560–13567 (2005).
4. Hokari,F.etal.MusclecontractileactivityregulatesSirt3proteinexpressioninrat
skeletal muscles. J Appl Physiol 109, 332–340 (2010).
5. Palacios, O. M. et al. Diet and exercise signals regulate SIRT3 and activate AMPK
and PGC-1alpha in skeletal muscle. Aging (Albany NY) 1, 771–783 (2009).
6. Hirschey, M. D. et al. SIRT3 regulates mitochondrial fatty-acid oxidation by
reversible enzyme deacetylation. Nature 464, 121–125 (2010).
7. Jing, E. et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin
signaling via altered mitochondrial oxidation and reactive oxygen species
production.ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesof
America 108, 14608–14613 (2011).
8. Kim, H. S. et al. SIRT3 is a mitochondria-localized tumor suppressor required for
maintenance of mitochondrial integrity and metabolism during stress. Cancer
Cell 17, 41–52 (2010).
9. Qiu, X., Brown, K., Hirschey, M. D., Verdin, E. & Chen, D. Calorie restriction
reducesoxidativestressbySIRT3-mediatedSOD2activation.CellMetab12,662–
667 (2010).
10. Someya, S. et al. Sirt3 mediates reduction of oxidative damage and prevention of
age-related hearing loss under caloric restriction. Cell 143, 802–812 (2010).
11. Sundaresan, N. R. et al. Sirt3 blocks the cardiac hypertrophic response by
augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. JC l i n
Invest 119, 2758–2771 (2009).
12. Tao, R. et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122
regulates MnSOD activity in response to stress. Mol Cell 40, 893–904 (2010).
13.Ahn,B.H.etal.AroleforthemitochondrialdeacetylaseSirt3inregulatingenergy
homeostasis. Proc Natl Acad Sci U S A 105, 14447–14452 (2008).
14. Hirschey, M. D. et al. SIRT3 Deficiency and Mitochondrial Protein
Hyperacetylation Accelerate the Development of the Metabolic Syndrome. Mol
Cell (2011).
15.Hallows,W.C. etal.Sirt3 promotes the ureacycle and fattyacid oxidation during
dietary restriction. Mol Cell 41, 139–149 (2011).
16.Kong,X.etal.Sirtuin3,anewtargetofPGC-1alpha,playsanimportantroleinthe
suppression of ROS and mitochondrial biogenesis. PLoS One 5, e11707 (2010).
17.Miniou,P.etal.Genetargetingrestrictedtomousestriatedmusclelineage.Nucleic
Acids Res 27, e27 (1999).
18.Postic,C.etal.Dualrolesforglucokinaseinglucosehomeostasisasdeterminedby
liverandpancreaticbetacell-specificgeneknock-outsusingCrerecombinase.The
Journal of biological chemistry 274, 305–315 (1999).
19. Shimazu, T. et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl
CoA synthase 2 and regulates ketone body production. Cell Metab 12, 654–661
(2010).
20. Seale, P. et al. Prdm16 determines the thermogenic program of subcutaneous
white adipose tissue in mice. The Journal of clinical investigation 121, 96–105
(2011).
21. Ortega-Molina, A. et al. Pten positively regulates brown adipose function, energy
expenditure, and longevity. Cell metabolism 15, 382–394 (2012).
22. Champy, M. F. et al. Mouse functional genomics requires standardization of
mouse handling and housing conditions. Mammalian genome : official journal of
the International Mammalian Genome Society 15, 768–783 (2004).
23.Champy,M.F.etal.Geneticbackgrounddeterminesmetabolicphenotypesinthe
mouse. Mamm Genome 19, 318–331 (2008).
24.Donovan,M.J.,Paulino,G.&Raybould,H.E.Activationofhindbrainneuronsin
response to gastrointestinal lipid is attenuated by high fat, high energy diets in
mice prone to diet-induced obesity. Brain Res 1248, 136–140 (2009).
25. West, D. B., Boozer, C. N., Moody, D. L. & Atkinson, R. L. Dietary obesity in nine
inbred mouse strains. Am J Physiol 262, R1025–1032 (1992).
26. Argmann, C. A., Chambon, P. & Auwerx, J. Mouse phenogenomics: the fast track
to "systems metabolism". Cell metabolism 2, 349–360 (2005).
27. Yamamoto, H. et al. NCoR1 is a conserved physiological modulator of muscle
mass and oxidative function. Cell 147, 827–839 (2011).
28. Canto, C. et al. AMPK regulates energy expenditure by modulating NAD1
metabolism and SIRT1 activity. Nature 458, 1056–1060 (2009).
29. Houtkooper, R. H. et al. The metabolic footprint of aging in mice. Sci Rep 1,1 3 4
(2011).
30.Frezza, C.,Cipolat,S.&Scorrano,L.Organelleisolation:functionalmitochondria
from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2, 287–295 (2007).
31. Koutnikova, H. et al. Identification of the UBP1 locus as a critical blood pressure
determinant using a combination of mouse and human genetics. PLoS Genet 5,
e1000591 (2009).
32. Piraud, M. et al. ESI-MS/MS analysis of underivatised amino acids: a new tool for
the diagnosis of inherited disorders of amino acid metabolism. Fragmentation
study of 79 molecules of biological interest in positive and negative ionisation
mode. Rapid Commun Mass Spectrom 17, 1297–1311 (2003).
33. Khan, H. A. Bioluminometric assay of ATP in mouse brain: Determinant factors
for enhanced test sensitivity. J Biosci 28, 379–382 (2003).
34. Berry, M. N. & Friend, D. S. High-yield preparation of isolated rat liver
parenchymal cells: a biochemical and fine structural study. The Journal of cell
biology 43, 506–520 (1969).
35. Watanabe, M. et al. Bile acids induce energy expenditure by promoting
intracellular thyroid hormone activation. Nature 439, 484–489 (2006).
Acknowledgements
This study was supported by grants of the Ecole Polytechnique Fe ´de ´rale de Lausanne, the
Swiss National Science Foundation (31003A-124713), and the European Research Council
Ideas program (Sirtuins; ERC-2008-AdG23118). JA is the Nestle Chair in Energy
Metabolism (NCEM). PJFM benefited from a FEBS fellowship. The authors thank all the
members of the Auwerx lab for inspiring discussions, and Dr. Manuel Serrano (CNIO,
Spain) for his help and support.
Author contributions
PJF-MandEJ(
1)contributedequallytothiswork.PJF-MandEJdirectedandperformedall
theexperiments.CCparticipatedintheimmunoprecipitationexperiments.PAparticipated
in the mitochondrial complex activities assays. TH and NM performed the primary
hepatocyte experiments. CC, EP and HY participated in the metabolic phenotyping of the
mouse models. VB and SH performed the blood metabolite analysis. KS and JA directed all
the work. PJF-M, CC, KS and JA wrote the manuscript. All authors reviewed the
manuscript.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: None of the authors have competing financial interests.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 425 | DOI: 10.1038/srep00425 7License: This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivative Works 3.0 Unported License. To view a copy
of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
How to cite this article: Fernandez-Marcos, P.J. et al. Muscle or liver-specific Sirt3
deficiency induces hyperacetylation of mitochondrial proteins without affecting global
metabolic homeostasis. Sci. Rep. 2, 425; DOI:10.1038/srep00425 (2012).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 425 | DOI: 10.1038/srep00425 8